Q2 2019 Adaptimmune Therapeutics PLC Earnings Call Transcript
Good morning and welcome to the second quarter of 2019 Adaptimmune earnings conference call. My name is Carla, and I will be your conference operator today. (Operator Instructions)
And now I would like to turn the call over to Juli Miller. Go ahead, please.
Good morning, and welcome to Adaptimmune's conference call to discuss our second quarter 2019 financial results and other business update. We issued 2 press releases earlier this morning, and I would ask you to please review the full text of our forward-looking statements there. As a brief reminder, we anticipate making projections during this call and actual results could differ materially due to a number of factors, including those outlined in our latest filings with the SEC.
James Noble, our Chief Executive Officer; Adrian Rawcliffe, incoming Adaptimmune's CEO; and Rafael Amado, our President of Research and Development are with me for the prepared portion of this call. Bill Bertrand, our Chief Operating Officer; Helen Tayton
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
